Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Interest & Investment Income (2023 - 2026)

Lexaria Bioscience's Interest & Investment Income history spans 4 years, with the latest figure at $1769.0 for Q1 2026.

  • Quarterly results put Interest & Investment Income at $1769.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Feb 2026 was $4787.0 (down 31.65% YoY), and the annual figure for FY2025 was $3017.0, down 78.92%.
  • Interest & Investment Income for Q1 2026 was $1769.0 at Lexaria Bioscience, up from $12.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $7319.0 in Q4 2023 to a low of -$1.0 in Q1 2024.
  • The 4-year median for Interest & Investment Income is $979.5 (2025), against an average of $2388.6.
  • The sharpest move saw Interest & Investment Income crashed 99.85% in 2024, then increased 9.09% in 2025.
  • Year by year, Interest & Investment Income stood at $7319.0 in 2023, then crashed by 99.85% to $11.0 in 2024, then rose by 9.09% to $12.0 in 2025, then surged by 14641.67% to $1769.0 in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $1769.0, $12.0, and $2816.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.